Dixon Technologies (India) Limited held meetings with institutional investors on September 21, 2026. The company confirmed that no unpublished price-sensitive information was shared during these discussions.

The disclosure was made pursuant to Regulations 30 and 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing references Para A of Part A of Schedule III of the same regulations.

Meeting Details

Ashish Kumar, President-Chief Legal Counsel and Group Company Secretary, signed the intimation filed with the BSE and NSE listing departments.

Dixon Technologies has acquired a 51% stake in Adivistar Electronics India Private Limited for ₹2.55 crore. The transaction was completed on September 21, 2026, through the subscription of equity shares at par value.

The acquisition formalizes Dixon’s control over the newly incorporated entity, which was established on August 13, 2026. Adivistar is designated as a wholly owned subsidiary structure where Dixon holds the majority interest, with no other promoter or group company interests disclosed in the target entity.

Strategic Rationale

Adivistar operates within the manufacturing sector, specifically as an original equipment manufacturer (OEM) for electronic devices, including smartphones. Dixon stated that this association aims to bolster its manufacturing excellence and execution capabilities.

The move strengthens Dixon’s foothold in the Android smartphone ecosystem in India. The company highlighted that the partnership supports Vivo’s leadership in the Indian business ecosystem, indicating a strategic alignment with key brand partners.

Transaction Details

Dixon subscribed to 25,50,000 equity shares of face value ₹10 each. The subscription money was paid on September 21, 2026. All requisite governmental and regulatory approvals for the acquisition have been obtained.

What the Numbers Show

Adivistar reported nil turnover as it had not yet commenced business operations at the time of incorporation and acquisition. The consideration of ₹2.55 crore represents the capital infusion required to establish the subsidiary’s operational framework for OEM activities. This structure allows Dixon to isolate specific manufacturing verticals while maintaining consolidated control.